[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
date : 6/26/2024
Tags: NCDs, Precision Cancer Medicine
Non-communicable diseases (NCDs), including cancer, are gaining prominence as significant health threats in low and middle-income countries (LMICs). However, they still lack sufficient traction and investment. Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. This event showcased C/Can’s innovative approach to cancer care in developing countries through case studies and provide an opportunity to discuss future collaboration opportunities with Japanese cancer and NCD stakeholders through networking sessions.
[Event Overview]
- Date & Time: Thursday, June 20, 2024, from 15:00 to 17:00 JST
- Format: In-Person (no virtual attendance available)
- Venue: Global Business Hub Tokyo
(Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, 100-0004 JAPAN) - Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Co-host: City Cancer Challenge (C/Can), Health and Global Policy Institute (HGPI)
[Program] (Titles omitted; in no particular order)
15:00-15:05 | Opening Remarks |
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare) | |
15:05-15:10 | Explanatory Introduction |
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (HGPI)) | |
15:10-15:30 | Keynote Speech “Current Status of Cancer Care in Developing Countries and the C/Can Model” |
Isabel Mestres (CEO, C/Can) | |
15:30-16:00 | Discussion “Voices from the Frontline and Expectations for Japan” |
(All speakers and attendees at the venue)
|
|
16:00-16:05 |
Remarks |
Ken Shibusawa (CEO, Shibusawa and Company, Inc.) | |
16:05-16:15 | Q&A |
16:15-17:00 | Networking Session |
About City Cancer Challenge (C/Can)
Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. Cancer is the second leading cause of premature death globally, with over 10 million cancer deaths in 2020. Low-and middle-income countries account for seven out of every ten deaths from cancer and the impact of these premature deaths further strains economies. By implementing tailored solutions, countries have the potential to save thousands of lives each year in an effective, sustainable, and scalable manner. C/Can has developed and implemented an innovative model that empowers local stakeholders such as policymakers, hospitals managers, healthcare professionals, academics, civil society representatives and patients to evaluate, plan and implement practical and sustainable solutions to improve cancer care at city level. For C/Can, cities offer a distinct environment to drive innovation in cancer care, which can be expanded to a national level. C/Can is present in 14 cities across Africa, Asia, Europe and Latin America. The global network continues to expand, with an open application process launched in 2023 to on-board new cities in 2025.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-10
[Event Report] HGPI Special Seminar Commemorating Dementia Month and World Alzheimer’s Month “Examining the Role of Industry in Creating a Dementia-Inclusive Society” (September 19, 2024)